Examples of 'enzalutamide' in a sentence
Meaning of "enzalutamide"
Enzalutamide (noun): A medication used in the treatment of prostate cancer. In English, this term is specific to the medical field and refers to a certain drug
Show more definitions
- A synthetic, non-steroidal pure antiandrogen developed for the treatment of metastatic castration-resistant prostate cancer.
How to use "enzalutamide" in a sentence
Basic
Advanced
enzalutamide
It is not known if enzalutamide is present in human milk.
Xtandi contains the active substance enzalutamide.
Enzalutamide is not for use in women.
The medicine contains the active substance enzalutamide.
Enzalutamide may cause seizures in overdose.
Investigational therapy other than enzalutamide.
Enzalutamide is contraindicated in women during pregnancy.
Process for the preparation of enzalutamide.
Potential for enzalutamide to affect exposures to other medicinal products.
The active substance is enzalutamide.
Enzalutamide is poorly water soluble.
In preclinical studies enzalutamide lacks androgen receptor agonist activity.
Enzalutamide was not phototoxic in vitro.
Effect of food on enzalutamide exposures.
Enzalutamide is primarily bound to albumin.
See also
It is not known whether enzalutamide or its metabolites are present in semen.
Enzalutamide to treat prostate cancer.
There is no antidote for enzalutamide.
Abiraterone and enzalutamide are currently approved for mCRPC patients.
No formal renal impairment study for enzalutamide has been completed.
Enzalutamide inhibits estrogen mediated growth in vitro and in vivo.
More severe in the enzalutamide.
Enzalutamide is extensively metabolized.
Food has no clinically significant effect on the extent of exposure to enzalutamide.
Enzalutamide is extensively metabolised.
Adverse events were consistent with the established safety profile of enzalutamide.
Enzalutamide does this by blocking the receptors to which these hormones attach.
Subject is able to swallow enzalutamide capsules and comply with study requirements.
Enzalutamide was negative for genotoxicity in a standard battery of in vitro and in vivo tests.
A review of concomitant medicinal products should therefore be conducted when initiating enzalutamide treatment.
These findings suggest that enzalutamide is a significantly more potent and effective antiandrogen in comparison.
A gradual dose reduction of the concomitant medicinal product may be necessary when stopping enzalutamide treatment.
The mechanisms of resistance to Enzalutamide are being intensively studied.
Mice in the control group received the same ground mouse chow but without enzalutamide.
N-desmethyl enzalutamide was not metabolized by CYPs in vitro.
If coadministration is necessary, increase the dose of enzalutamide.
N-desmethyl enzalutamide was not metabolised by CYPs in vitro.
In certain embodiments, the androgen receptor inhibitor is enzalutamide.
Each capsule contains 40 mg of enzalutamide as a solution in caprylocaproyl polyoxylglycerides.
Enzalutamide a novel and potent anti-androgen was used as positive control.
Even at this early stage, enzalutamide is a game changer.
Enzalutamide is a novel and potent anti-androgen, and serves as a positive control.
In preclinical studies, the absorption of enzalutamide was increased when dissolved in caprylocaproyl macrogolglycerides.
The method according to claim 3, wherein the androgen receptor inhibitor is enzalutamide.
The solubility of enzalutamide is increased by caprylocaproyl macrogolglycerides as emulsifier / surfactant.
Long-term animal studies to evaluate the carcinogenic potential of enzalutamide have not been conducted.
In this product, the solubility of enzalutamide is increased by caprylocaproyl macrogolglycerides as emulsifier / surfactant.
DHT-stimulated proliferation was blocked by enzalutamide in both cell lines.
By blocking androgens, enzalutamide stops prostate cancer cells from growing and dividing.
Each soft capsule contains 40 mg of enzalutamide.
